Kamada (KMDA) Acquisitions (2021)

Kamada's (KMDA) quarterly Acquisitions came in at -$95.0 million in Q4 2021, down 6666.31% on a QoQ basis from -$1.4 million in Q1 2021.

Kamada (KMDA) Acquisitions (2021) Analysis & Trends

Kamada (KMDA) has 1 years of Acquisitions data on file, last reported at -$95.0 million in Q4 2021.

Quarterly Acquisitions changed N/A year-over-year to -$95.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$96.4 million (changed N/A YoY) and the FY2021 annual result came in at -$96.4 million, changed N/A from the prior year.
Acquisitions declined to -$95.0 million in Q4 2021, from -$1.4 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of -$1.4 million in Q1 2021 to a low of -$95.0 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-	-
2	Teva Pharmaceutical Industries	43.01 Bn	39.35 Bn	2.15 Bn	-
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	-
5	United Therapeutics	22.17 Bn	19.51 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.85 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-	-
10	Kamada	465.78 Mn	436.31 Mn	22.47 Mn	-

Download Data

Date	Value
Dec 31, 2021	-95.00 Mn
Mar 31, 2021	-1.40 Mn